A recent study found that a DMT/harmine formulation blurs the brain’s distinction between self and other faces, disrupting ...

Users are turning to ChatGPT to guide them through acid trips. Plus Microsoft stacks the deck in dodgy medical ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological ...

The Stanley Brothers created Charlotte's Web, the CBD supplement that’s worked wonders on seizures. Now they are developing ...

DelveInsight's Traumatic Brain Injury pipeline report depicts a robust space with 20+ active players working to develop 22+ ...

Psychedelics are drugs that cause an altered state of consciousness. Dölen and Tippett discussed plant based compounds like ...

Life Sciences (ATAI) stock rises as the company and Beckley Psytech said their psychedelic drug BPL-003 hit main goals in a ...

Some people believe chatbots like ChatGPT can provide an affordable alternative to in-person psychedelic-assisted therapy.

Atai Life Sciences’ psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the next stage of the biotech’s planned merger with mental health company ...

Cosmo Feilding Mellen – currently Beckley's chief executive, who is slated to serve as chief strategy officer of the merged ...

Life Sciences & Beckley Psytech announce positive results from phase 2b study of BPL-003 in patients with treatment-resistant depression: New York Wednesday, July 2, 2025, 10 ...